Adma Biologics (ADMA) Non-cash Items (2015 - 2025)

Adma Biologics has reported Non-cash Items for 11 years, with the latest figure at $39.4 million in Q4 2025.

• For the quarter ending Q4 2025, Non-cash Items fell 42.18% year-over-year to $39.4 million; the trailing twelve-month figure through Dec 2025 stood at $39.4 million (down 42.18% YoY), and the FY2025 full-year result was $39.4 million, down 42.18% from the prior year.
• Non-cash Items for Q4 2025 stood at $39.4 million, up from $2.8 million in the prior quarter.
• The five-year high for Non-cash Items was $68.1 million in Q4 2024, with the low at $2.5 million in Q3 2024.
• Historically, Non-cash Items has averaged $10.2 million across 5 years, with a median of $5.3 million in 2021.
• Annual changes were most pronounced in 2024 — Non-cash Items soared 664.16% — and 2025, when it tumbled 55.27%.
• Adma Biologics' Non-cash Items stood at $5.5 million in 2021, then surged by 38.38% to $7.6 million in 2022, then advanced by 16.67% to $8.9 million in 2023, then soared by 664.16% to $68.1 million in 2024, then plunged by 42.18% to $39.4 million in 2025.
• The last three Non-cash Items figures came in at $39.4 million (Q4 2025), $2.8 million (Q3 2025), and $11.1 million (Q2 2025), per Business Quant data.